Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07356856
PHASE1

Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors

Sponsor: The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

View on ClinicalTrials.gov

Summary

In this study, microtransplantation (MST) will be administrated to patients diagnosed with advanced / relapsed solid tumors to assess the therapeutic efficacy and safety of conventional chemotherapy in combination with MST for the treatment of advanced/relapsed solid tumors.

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2026-01-15

Completion Date

2028-06-01

Last Updated

2026-01-21

Healthy Volunteers

No

Interventions

BIOLOGICAL

MST

conventional chemotherapy with microtransplantation(MST). Microtransplantation, which is the infusion of granulocyte colony stimulating factor (G-CSF) mobilized HLA-mismatched peripheral blood mononuclear cells (GPBMC)

Locations (3)

Innovvy(Beijing) Biomedical Technology Co., Ltd

Haidian, Beijing Municipality, China

Minzu Hospital of Guangxi Zhuang Autonomous Region

Nanning, Guangxi, China

The First People's Hospital of Nanning

Nanning, Guangxi, China